Viracta Therapeutics (VIRX) Short Interest Ratio & Short Volume → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free VIRX Stock Alerts $0.81 -0.03 (-3.57%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Viracta Therapeutics Short Interest DataCurrent Short Volume686,700 sharesPrevious Short Volume648,000 sharesChange Vs. Previous Month+5.97%Dollar Volume Sold Short$535,626.00Short Interest Ratio / Days to Cover6.2Last Record DateApril 15, 2024Outstanding Shares39,270,000 sharesFloat Size27,490,000 sharesShort Percent of Float2.50%Today's Trading Volume33,087 sharesAverage Trading Volume133,594 sharesToday's Volume Vs. Average25% Short Selling Viracta Therapeutics ? Sign up to receive the latest short interest report for Viracta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIRX Short Interest Over TimeVIRX Days to Cover Over TimeVIRX Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Viracta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024686,700 shares $535,626.00 +6.0%2.5%6.2 $0.78 3/31/2024648,000 shares $660,960.00 +2.2%2.4%6.8 $1.02 3/15/2024634,300 shares $631,762.80 -7.1%2.3%5.7 $1.00 2/29/2024683,000 shares $556,645.00 +0.6%2.5%5 $0.82 2/15/2024678,800 shares $433,753.20 +4.5%2.5%4.5 $0.64 1/31/2024649,900 shares $370,443.00 +0.4%2.4%4 $0.57 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024647,500 shares $384,226.50 -1.9%2.4%3.8 $0.59 12/31/2023660,300 shares $376,371.00 -14.9%2.5%3.8 $0.57 12/15/2023776,100 shares $361,973.04 +19.3%2.9%4.6 $0.47 11/30/2023650,700 shares $316,890.90 -8.2%2.4%4.9 $0.49 11/15/2023708,700 shares $425,503.48 +3.0%2.6%7.3 $0.60 10/31/2023688,200 shares $424,275.30 +12.0%2.6%7.5 $0.62 10/15/2023614,700 shares $436,437.00 -2.7%2.3%7.6 $0.71 9/30/2023632,000 shares $657,280.00 -4.3%2.4%7 $1.04 9/15/2023660,200 shares $838,454.00 -5.3%2.5%7.8 $1.27 8/31/2023697,200 shares $1.00 million -4.4%2.6%6.8 $1.44 8/15/2023729,100 shares $947,830.00 +5.2%2.7%4.5 $1.30 7/31/2023692,900 shares $1.07 million -3.9%2.6%2.8 $1.55 7/15/2023721,000 shares $1.05 million -1.0%2.7%2.9 $1.45 6/30/2023728,500 shares $1.03 million -7.8%2.8%3 $1.41 6/15/2023789,900 shares $1.26 million +14.0%3.0%3.3 $1.59 5/31/2023693,200 shares $921,956.00 +12.4%2.6%3.2 $1.33 5/15/2023616,700 shares $807,877.00 -2.2%2.3%3.4 $1.31 4/30/2023630,800 shares $813,732.00 +2.0%2.4%8.4 $1.29 4/15/2023618,300 shares $902,718.00 -2.5%2.3%9.6 $1.46 3/31/2023634,000 shares $1.01 million -19.5%2.4%8.4 $1.59 3/15/2023787,800 shares $1.33 million +51.7%3.0%8.7 $1.69 2/28/2023519,200 shares $882,640.00 +3.9%2.0%4.9 $1.70 2/15/2023499,500 shares $994,005.00 +5.6%1.9%4.5 $1.99 1/31/2023473,000 shares $983,840.00 -2.5%1.8%3.8 $2.08 1/15/2023485,300 shares $1.10 million +3.2%1.8%3.9 $2.26 12/30/2022470,300 shares $686,638.00 -15.1%1.8%3.8 $1.46 12/15/2022553,600 shares $1.06 million -0.1%2.1%5.2 $1.92 11/30/2022553,900 shares $1.29 million +7.3%2.1%5.1 $2.32 11/15/2022516,200 shares $1.50 million +8.8%2.0%4.8 $2.90 10/31/2022474,600 shares $1.87 million -9.6%1.9%4.7 $3.93 10/15/2022525,100 shares $1.97 million -4.4%2.0%5.1 $3.75 9/30/2022549,000 shares $2.34 million +9.3%2.1%5 $4.27 9/15/2022502,100 shares $2.81 million -3.9%2.0%2.6 $5.59 8/31/2022522,300 shares $2.12 million +0.6%2.0%2.3 $4.05Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. VIRX Short Interest - Frequently Asked Questions What is Viracta Therapeutics' current short interest? Short interest is the volume of Viracta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 686,700 shares of VIRX short. 2.50% of Viracta Therapeutics' shares are currently sold short. Learn More on Viracta Therapeutics' current short interest. What is a good short interest ratio for Viracta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIRX shares currently have a short interest ratio of 6.0. Learn More on Viracta Therapeutics's short interest ratio. What is a good short interest percentage for Viracta Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.50% of Viracta Therapeutics' floating shares are currently sold short. Is Viracta Therapeutics' short interest increasing or decreasing? Viracta Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 686,700 shares, an increase of 6.0% from the previous total of 648,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Viracta Therapeutics' float size? Viracta Therapeutics currently has issued a total of 39,270,000 shares. Some of Viracta Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Viracta Therapeutics currently has a public float of 27,490,000 shares. How does Viracta Therapeutics' short interest compare to its competitors? 2.50% of Viracta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Viracta Therapeutics: Fortress Biotech, Inc. (13.02%), Theratechnologies Inc. (0.13%), ImmunoPrecise Antibodies Ltd. (1.58%), JanOne Inc. (1.72%), Enlivex Therapeutics Ltd. (1.50%), Daré Bioscience, Inc. (0.25%), CASI Pharmaceuticals, Inc. (0.99%), NextCure, Inc. (0.54%), DURECT Co. (3.19%), BriaCell Therapeutics Corp. (4.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Viracta Therapeutics stock? Short selling VIRX is an investing strategy that aims to generate trading profit from Viracta Therapeutics as its price is falling. VIRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viracta Therapeutics? A short squeeze for Viracta Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRX, which in turn drives the price of the stock up even further. How often is Viracta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: FBIO Short Squeeze THTX Short Squeeze IPA Short Squeeze JAN Short Squeeze ENLV Short Squeeze DARE Short Squeeze CASI Short Squeeze NXTC Short Squeeze DRRX Short Squeeze BCTX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith